This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Naeja Pharmaceuticals Inc., Pantherix, Ltd.. Active years: 2003-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Edmonton, CA (2003)
- Alberta, CA (2005)
Company Filing History:
Years Active: 2003-2005
Title: Andhe V Narender Reddy: Innovator in Pharmaceutical Chemistry
Introduction
Andhe V Narender Reddy is a notable inventor based in California, recognized for his contributions to pharmaceutical chemistry. He holds 2 patents that focus on innovative compounds with potential therapeutic applications. His work primarily addresses the need for effective antibacterial agents and cysteine protease inhibitors.
Latest Patents
One of his latest patents is titled "3-(Heteroaryl acetamido)-2-oxo-azetidine-1-sulfonic acids derivatives as antibacterial agents." This invention relates to novel syn isomers of racemates and optical isomers of 3-(heteroaryl acetamido)-2-oxo-azetidine-1-sulfonic acids. These compounds are designed for treating infections caused by gram-negative pathogenic bacteria. Another significant patent is "Substituted azetidin-2-ones as cysteine protease inhibitors." This invention describes substituted azetidin-2-ones and pharmaceutical compositions containing such compounds, which are used as inhibitors of cysteine proteases, particularly cathepsins.
Career Highlights
Throughout his career, Andhe has worked with various companies, including Naeja Pharmaceuticals Inc. and Pantherix, Ltd. His experience in these organizations has contributed to his expertise in developing pharmaceutical innovations.
Collaborations
Andhe has collaborated with notable professionals in the field, including Rajeshwar Singh and Ronald G Micetich. These collaborations have further enhanced his research and development efforts.
Conclusion
Andhe V Narender Reddy is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in antibacterial and protease inhibitor compounds. His contributions continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile